SCHEMBL30457749

SCHEMBL30457749

N#Cc1ccc(O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312264 1.00
SCHEMBL7285319 0.83 MMP3 (0.52)
SCHEMBL941512 0.76
SCHEMBL7921009 0.76
SCHEMBL14473398 0.76 ESR1 (0.53)
SCHEMBL12630708 0.73 CHEK1 (0.51)
SCHEMBL1026572 0.73 ALDH1A1 (0.48)
SCHEMBL156136 0.71
SCHEMBL42349 0.71
SCHEMBL1145963 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025102293-A1 NEUROACTIVE ANDROGEN RECEPTOR MODULATOR AND USE THEREOF 北京脑科学与类脑研究所 2025-05-22 WO disclosed
CN-113766914-B Pentaneamidine analogues and uses thereof 美商奥润沙公司 2024-02-13 CN disclosed
CN-112154142-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2023-11-21 CN disclosed
CN-110475785-B Peptide compound, method for producing same, composition for screening, and method for selecting peptide compound 富士胶片株式会社 2023-06-13 CN disclosed